Internal Medicine Doctors in Altus, OK Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Sung Deuk Kim, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 E Pecan St, Altus, OK 73521 Phone: 580-379-5000    Fax: 580-379-5999

Willard Perez, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 201 S Park Ln, Altus, OK 73521 Phone: 580-482-9020    Fax: 580-480-3113

Addi S Abuelshar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 E Pecan, Jcmh/ Hospitalist Office, Altus, OK 73521 Phone: 580-379-5992    Fax: 580-379-5999

Dr. Joe L Leverett, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 S Park Ln, Altus, OK 73521 Phone: 580-379-6650    Fax: 580-379-6659

Dr. Nicole A Williamson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 E Pecan St, Altus, OK 73521 Phone: 580-379-5000    Fax: 580-379-5509

Nizar Ghazi Al-nimri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 E Pecan St, Altus, OK 73521 Phone: 580-379-5000    Fax: 580-379-5999

News Archive

MSC-mediated RNAi transfer holds promise for Huntington's disease

A team of researchers at the UC Davis Institute for Regenerative Cures has developed a technique for using stem cells to deliver therapy that specifically targets the genetic abnormality found in Huntington's disease, a hereditary brain disorder that causes progressive uncontrolled movements, dementia and death.

Essential criteria for clinical diagnosis of restless legs syndrome

We've all experienced abnormal sensations in our legs at one time or another, but for as many as 10 percent of the US population, restless legs syndrome (RLS) is a daily occurrence. Characterized by throbbing, pulling, tingling, itching, and crawling sensations, RLS is a neurological disorder that produces unpleasant physical sensations in the extremities and an urge to counteract that sensation by movement.

Regulus' RG-012 receives orphan medicinal product designation in EU for treatment of Alport syndrome

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that the European Commission has granted orphan medicinal product designation for RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 ("miR-21") for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.

New HMO dental plans for Californian residents

The state's largest dental plan today unveiled two updated options under its DeltaCare® USA Individual and Family Program. The revamped HMO dental plans include procedures previously not covered and define copayments for a wider range of benefits, including orthodontics for adults and children.

SAFit-ligands provide foundation for novel treatment of stress-related psychiatric disorders

The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52.

Read more Medical News

› Verified 4 days ago